Proxy adviser ISS backs ouster of Progenics CEO in activist battle

28th October 2019 Uncategorised 0

Velan Capital is angling to muscle onto Progenics’ board and oust its CEO after the drugmaker opted to sell instead of negotiating over board seats. And an influential shareholder advisory firm has thrown its weight behind that effort, backing three of the activist’s board nominees. But Velan still thinks that’s not enough.

More: Proxy adviser ISS backs ouster of Progenics CEO in activist battle
Source: fierce